Verition Fund Management LLC reduced its position in shares of Exponent, Inc. (NASDAQ:EXPO – Free Report) by 58.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,511 shares of the business services provider’s stock after selling 3,536 shares during the period. Verition Fund Management LLC’s holdings in Exponent were worth $289,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Quarry LP purchased a new stake in Exponent in the 2nd quarter valued at about $25,000. Whittier Trust Co. of Nevada Inc. increased its position in shares of Exponent by 166.5% during the second quarter. Whittier Trust Co. of Nevada Inc. now owns 517 shares of the business services provider’s stock valued at $49,000 after acquiring an additional 323 shares during the last quarter. USA Financial Formulas bought a new stake in Exponent during the third quarter worth $60,000. GAMMA Investing LLC boosted its position in Exponent by 64.6% in the third quarter. GAMMA Investing LLC now owns 624 shares of the business services provider’s stock worth $72,000 after purchasing an additional 245 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. grew its stake in Exponent by 70.5% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 873 shares of the business services provider’s stock valued at $83,000 after purchasing an additional 361 shares during the period. 92.37% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling at Exponent
In related news, Director Carol Lindstrom sold 1,039 shares of Exponent stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $96.32, for a total value of $100,076.48. Following the completion of the sale, the director now owns 5,871 shares of the company’s stock, valued at approximately $565,494.72. This trade represents a 15.04 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Paul R. Johnston sold 14,000 shares of the company’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $104.60, for a total transaction of $1,464,400.00. Following the sale, the director now directly owns 80,742 shares in the company, valued at approximately $8,445,613.20. This trade represents a 14.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 30,339 shares of company stock worth $3,103,065 over the last three months. 2.10% of the stock is currently owned by insiders.
Exponent Price Performance
Exponent Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Shareholders of record on Friday, December 6th will be given a $0.28 dividend. This represents a $1.12 annualized dividend and a yield of 1.20%. The ex-dividend date of this dividend is Friday, December 6th. Exponent’s dividend payout ratio is 54.11%.
About Exponent
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Further Reading
- Five stocks we like better than Exponent
- What is a SEC Filing?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- 10 Best Airline Stocks to Buy
- Texas Instruments: The Old-School Tech Titan Still Delivering
- How to Invest in the Best Canadian StocksĀ
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO – Free Report).
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.